Based on the aforementioned bioinformatics analysis, we will pay more attention to the effects of immune microenvironment regulation, ERBB signaling pathway, and MAPK signaling pathway on the occurrence and development of GBM. The gene discussed is EGFR; the disease is glioblastoma.